Australia consults on automatic adoption of PIC/S GMP guide for pharma
This article was originally published in SRA
Australia's Therapeutic Goods Administration is inviting feedback on it proposal to "automatically adopt" the latest good manufacturing practice guideline issued by the Pharmaceutical Inspection and Co-operation scheme (PIC/S) 1-4.
You may also be interested in...
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
The Canadian medtech regulator has recommended updating its list of recognized medical device standards that manufacturers can rely on to demonstrate compliance with local safety, effectiveness and labeling requirements.
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. While the European Medicines Agency has launched an investigation, Australia is examining the need for specific warnings about risks of vaccination in the very frail elderly or terminally ill patients.